Life Sciences Mergers and Acquisitions: Q&A

September 11, 2020

Dechert partnered with Practical Law on their Q&A guide to mergers and acquisitions (M&A) in the life sciences sector, with a focus on pharma and medicines. 

In this Q&A, life sciences experts from Dechert’s Corporate and Intellectual Property practices provide a high-level overview of the factors affecting asset and share acquisitions in the sector and the key considerations for buyers and sellers. They discuss the motivations of the parties; acquisition and consideration structures; risks; the due diligence process; third party consents; liability and indemnity clauses and key negotiation points in sale and purchase agreements.

Read "Life Sciences Mergers and Acquisitions: Q&A".

Subscribe to Dechert Updates